1. jiocsells
2. ffnorwn
3. loenoor
4. jhkind9
5. JimmyMcGill
1.loenoor 01/03/2018
Wellington Management Company hold 5% now
2.ffnorwn 03/20/2018
Zealand Pharma's first Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia successfully meets its primary objective
3.jiocsells 01/24/2018
its time to get back to $18
4.ffnorwn 02/15/2018
Zealand Pharma's dasiglucagon Phase 2a results at the 11th International Conference on ATTD
5.jiocsells 04/26/2018
Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome
6.jiocsells 01/19/2018
Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018
7.ffnorwn 03/07/2018
Zealand Pharma 2017 full-year results in line with guidance - considerable progress in the clinical portfolio
8.loenoor 02/21/2018
Zealand Pharma reports completion of the first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia
9.jiocsells 02/07/2018
Reports Q4 royalty revenue of DKK 11.3 million/$1.8 million for Q4 2017
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW